In this article, we discuss the 13 most profitable pharmaceutical stocks to buy.
Keep Reading →
December 18 - Hedge Funds, News
In this article, we shall discuss the 12 best diabetes stocks to buy now.
Keep Reading →
November 26 - Business, Hedge Funds, Industries, News
In this article, we shall cover the top 10 oncology companies in the world.
Keep Reading →
October 13 - News
In this article, we will be taking a look at the 50 most valuable companies in the world by market cap.
Keep Reading →
July 27 - Lists, News
In this article, we will take a look at 12 best value dividend stocks to buy.
Keep Reading →
October 25 - Hedge Funds, News
In this article, we will be taking a look at the 10 healthcare stocks to watch in light of Biden's 60 Minutes interview.
Keep Reading →
October 5 - Hedge Funds, News
In this article, we will be taking a look at the 5 best ADR stocks to buy now.
Keep Reading →
August 29 - Hedge Funds, News
In this article, we will be taking a look at 10 healthcare stocks to watch amid Senate's healthcare bill.
Keep Reading →
August 14 - Hedge Funds, News
Carillon Tower Advisers, an investment management firm, published its “Carillon Eagle Growth & Income Fund” first quarter 2022 investor letter – a copy of which can be ...
Keep Reading →
July 5 - Hedge Fund Investor Letters, News
In this article, we discuss the 10 affordable blue chip stocks to buy now.
Keep Reading →
June 15 - Hedge Funds, News
Baron Funds, an asset management firm, published its “Baron Health Care Fund” first quarter 2022 investor letter – a copy of which can be downloaded here.
Keep Reading →
June 14 - Hedge Fund Investor Letters, News
Below we present the list of the top 5 healthcare stocks the experts at Sphera Global Healthcare Fund are buying.
Keep Reading →
February 20 - Hedge Funds, News
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Keep Reading →
December 6 - Hedge Funds, News
In this article, we will be taking a look at the 10 best diabetes stocks to buy now.
Keep Reading →
November 2 - Hedge Funds, News
The Insider Monkey team has completed processing the quarterly 13F filings for the December quarter submitted by the hedge funds and other money managers included in our extensive...
Keep Reading →
March 29 - Hedge Funds, News
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the...
Keep Reading →
December 21 - Hedge Funds, News
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Keep Reading →
November 4 - Hedge Funds, News
In a world dominated by a pandemic, you might wonder how its affecting the 10 biggest pharmaceutical companies in the world in 2020 (click to skip ahead and see the top 3 pharma...
Keep Reading →
September 13 - Lists
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Keep Reading →
September 9 - Hedge Funds, News
Since June 8, 2020…When Speculation Bubbled About A Possible AstraZeneca-Gilead Sciences Combination [see vertical line in above chart]…The Following “Deal” Metrics Have...
Keep Reading →
August 29 - Market Movers, Stock Analysis
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Keep Reading →
July 12 - Hedge Funds, News
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We...
Keep Reading →
June 9 - Hedge Funds, News
The COVID-19 vaccine race officially goes into high gear with the announcement of USA’s plan to test the 6-odd top vaccine candidates across upwards of 150,000 volunteers (...
Keep Reading →
May 31 - Stock Analysis
Coronavirus is probably the #1 concern in investors' minds right now. It should be.
Keep Reading →
May 4 - Hedge Funds, News
Coronavirus is probably the #1 concern in investors' minds right now. It should be.
Keep Reading →
March 12 - Hedge Funds, News
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.
Keep Reading →
January 13 - Hedge Funds, News
Concerns over rising interest rates and expected further rate increases have hit several stocks hard during the fourth quarter of 2018.
Keep Reading →
December 6 - Hedge Funds, News
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade.
Keep Reading →
October 9 - Hedge Funds, News
At Insider Monkey we follow nearly 750 of the best-performing investors and even though many of them lost money in the last couple of months of 2018 (some actually delivered very...
Keep Reading →
June 14 - Hedge Funds, News
The extended weekend is now over, and Wall Street is once again paying attention to the U.S.
Keep Reading →
May 28 - News
Before we spend days researching a stock idea we'd like to take a look at how hedge funds and billionaire investors recently traded that stock.
Keep Reading →
March 26 - Hedge Funds, News
The market has been volatile as the Federal Reserve continues its rate hikes to normalize the interest rates.
Keep Reading →
December 12 - Hedge Funds, News
Fisher Investments was founded in 1979 by billionaire Ken Fisher.
Keep Reading →
November 13 - Dividend Stocks, Hedge Funds, News
Daniel Loeb's hedge fund, Third Point, has trimmed the number of nominees it is making to the Campbell Soup board to five, sources tell CNBC.
Keep Reading →
November 9 - Hedge Funds, Insider Trading
Curious to know which treatments are among the 15 bestselling most profitable drugs of all time? The pharmaceutical industry has been a topic of interest for investors, market...
Keep Reading →
November 24 - News
The top 10 largest pharmaceutical companies by revenue in 2017 are leading companies that have a large geographical presence, loyal customer base and technologically advanced ...
Keep Reading →
November 23 - News
Opus Point Partners was founded by Michael S. Weiss and Dr. Lindsay A. Rosenwald in 2009. Prior to launching Opus Point Partners, Mr. Weiss and Dr.
Keep Reading →
August 25 - Hedge Funds, News
"U.S. equities traded mostly lower on Friday as investors digested a tough week for retailers as well as mixed economic data.
Keep Reading →
May 12 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech
Before we get to the list of 7 over-the-counter diet pills that work without exercise, we should ask ourselves if there exists such a thing. The short answer is no.
Keep Reading →
April 12 - Lists, News
AstraZeneca PLC (ADR) (NYSE:AZN) has acknowledged the receipt of the Complete Response Letter (CRL) from the U.S.
Keep Reading →
March 21 - News, Stock Analysis
In an effort to enhance collaboration with Circassia Pharmaceuticals, AstraZeneca PLC (ADR) (NYSE:AZN) has acquired an equity stake valued at $50 million in the respiratory biopharmaceutical...
Keep Reading →
March 20 - News, Stock Analysis
Lynparza, an ovarian cancer treatment developed by AstraZeneca PLC (ADR) (NYSE:AZN) has demonstrated its ability to slow down disease progression.
Keep Reading →
March 16 - News, Stock Analysis
It’s been a big week for PARP inhibitors.
Keep Reading →
March 15 - News, Stock Analysis
Are you interested in knowing the 7 Most Popular Diet Pills That Work Fast Without Exercise? I mean what better way to lose weight than to simply pop some pills and let the fat...
Keep Reading →
March 15 - Lists, News
AstraZeneca plc (ADR) (NYSE:AZN) is reconsidering some of its rejected drugs, as they could possess potential in curing a disease they were not initially meant to treat.
Keep Reading →
March 14 - News, Stock Analysis
Hutchison China MediTech Limited and AstraZeneca plc (ADR) (NYSE:AZN) are to present data from their phase II clinical trials of Savolitinib, at the upcoming 2017 Genitourinary...
Keep Reading →
February 15 - News, Stock Analysis
Trials of rival drugs from AstraZeneca PLC (ADR) (NYSE:AZN) and TESARO Inc (NASDAQ:TSRO) will determine the adoption of the PARP inhibitor, Rubraca from Clovis Oncology Inc (NASDAQ...
Keep Reading →
January 31 - News, Stock Analysis
The US Food and Drug Administration (FDA) has confirmed that Symbicort (budesonide/formoterol) Inhalation Aerosol is worth being granted paediatric exclusivity.
Keep Reading →
January 30 - News, Stock Analysis
AstraZeneca plc (ADR) (NYSE:AZN) share price could receive a major boost on the company pursuing a label expansion for its blockbuster Tagrisso.
Keep Reading →
January 3 - News, Stock Analysis
AstraZeneca plc (ADR) (NYSE:AZN)’s chief executive officer has said that the long negotiation process that the NHS undertakes with drugmakers before approving medications is...
Keep Reading →
December 30 - News, Stock Analysis